{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["15"],"submitter":["Kong Y"],"pubmed_abstract":["<h4>Background</h4>Colorectal cancer (CRC) is one of the most common cancers worldwide. Colonoscopy is the gold standard for CRC screening, but its effectiveness in population-based programs requires further evaluation.<h4>Methods</h4>We conducted a follow-up study in Xuzhou, China. Participants were recruited from 2014 to 2021, with follow-up continuing until December 2023. The study comprised two components: 1) an active follow-up to assess treatment outcomes for patients with colorectal advanced neoplasia (CAN) detected during screening; 2) a passive follow-up to compare CRC incidence and mortality between participants who underwent colonoscopy and those who refused it.<h4>Results</h4>The active follow-up included 196 participants, while 15,440 were included the passive follow-up (4,029"],"journal":["Frontiers in oncology"],"pagination":["1689066"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12646884"],"repository":["biostudies-literature"],"pubmed_title":["Effect of colonoscopy screening on the risk of colorectal cancer in China: a follow-up study."],"pmcid":["PMC12646884"],"pubmed_authors":["Zhang G","Jin R","Dong Z","Ma Y","Zhang P","Zhuo L","Dong D","Liu","Luo X","Wang Y","Kong Y","Gao S","Zhao H"],"additional_accession":[]},"is_claimable":false,"name":"Effect of colonoscopy screening on the risk of colorectal cancer in China: a follow-up study.","description":"<h4>Background</h4>Colorectal cancer (CRC) is one of the most common cancers worldwide. Colonoscopy is the gold standard for CRC screening, but its effectiveness in population-based programs requires further evaluation.<h4>Methods</h4>We conducted a follow-up study in Xuzhou, China. Participants were recruited from 2014 to 2021, with follow-up continuing until December 2023. The study comprised two components: 1) an active follow-up to assess treatment outcomes for patients with colorectal advanced neoplasia (CAN) detected during screening; 2) a passive follow-up to compare CRC incidence and mortality between participants who underwent colonoscopy and those who refused it.<h4>Results</h4>The active follow-up included 196 participants, while 15,440 were included the passive follow-up (4,029","dates":{"release":"2025-01-01T00:00:00Z","publication":"2025","modification":"2026-06-05T16:49:10.923Z","creation":"2026-05-19T03:11:41.274Z"},"accession":"S-EPMC12646884","cross_references":{"pubmed":["41312170"],"doi":["10.3389/fonc.2025.1689066"]}}